Zobrazeno 1 - 10
of 1 383
pro vyhledávání: '"CD79 Antigens"'
Autor:
Meriranta L; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Sorri S; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Huse K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Liu X; Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Spasevska I; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Zafar S; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Chowdhury I; Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Dufva O; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Sahlberg E; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Tandarić L; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Karjalainen-Lindsberg ML; Department of Pathology, Helsinki University Hospital, Helsinki, Finland., Hyytiäinen M; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Varjosalo M; Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Leppä S; Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2024 Sep 03; Vol. 5 (5), pp. 331-352.
Autor:
Corcoran SR; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland.; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts., Phelan JD; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland., Choi J; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland., Shevchenko G; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Fenner RE; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Yu X; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland., Scheich S; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland., Hsiao T; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland., Morris VM; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland.; Department of Biology, Johns Hopkins University, Baltimore, Maryland., Papachristou EK; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Kishore K; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., D'Santos CS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Ji Y; Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany., Pittaluga S; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland., Wright GW; Biometrics Research Program, National Cancer Institute, NIH, Bethesda, Maryland., Urlaub H; Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany., Pan KT; University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Oellerich T; University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Muppidi J; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland., Hodson DJ; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Sep 04; Vol. 14 (9), pp. 1653-1674.
Autor:
Sil A; Allergy Immunology Unit, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India., Basu S; Allergy Immunology Unit, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India., Arora K; Allergy Immunology Unit, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India., Khubchandani R; Senior Consultant and In-charge, Pediatric Rheumatology Clinic, SRCC Children's Hospital, Mumbai, India., Rawat A; Allergy Immunology Unit, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India., Suri D; Allergy Immunology Unit, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India. surideepti@gmail.com.
Publikováno v:
Journal of clinical immunology [J Clin Immunol] 2024 Aug 31; Vol. 44 (8), pp. 187. Date of Electronic Publication: 2024 Aug 31.
Autor:
Liu Y; BeiGene (Shanghai) Co., Ltd., Shanghai, China., Ma X; BeiGene (Beijing) Co., Ltd., Beijing, China., Wu X; BeiGene (Shanghai) Co., Ltd., Shanghai, China., Hou X; BeiGene (Beijing) Co., Ltd., Beijing, China., Jin W; BeiGene (Beijing) Co., Ltd., Beijing, China., Fu L; BeiGene (Beijing) Co., Ltd., Beijing, China., Xun X; BeiGene (Shanghai) Co., Ltd., Shanghai, China., Yu Y; BeiGene (Shanghai) Co., Ltd., Shanghai, China., Shen Z; BeiGene (Beijing) Co., Ltd., Beijing, China.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1079-1089. Date of Electronic Publication: 2024 May 22.
Autor:
Fujii K; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-Ku, Nagoya, 467-8601, Japan., Inagaki A; Department of Hematology and Oncology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.; Nagoya City University West Medical Center, Nagoya, Japan., Masaki A; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-Ku, Nagoya, 467-8601, Japan., Sugiura M; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-Ku, Nagoya, 467-8601, Japan., Suzuki T; Department of Hematology and Oncology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan., Ishida T; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kusumoto S; Department of Hematology and Oncology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan., Iida S; Department of Hematology and Oncology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan., Inagaki H; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-Ku, Nagoya, 467-8601, Japan. hinagaki@med.nagoya-cu.ac.jp.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 2041-2050. Date of Electronic Publication: 2024 Feb 27.
Autor:
Xie Z; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Qin Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China., Chen X; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Yang S; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Yang J; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Gui L; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Liu P; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., He X; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Zhou S; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Zhang C; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Tang L; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., Shi Y; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China. syuankai@cicams.ac.cn.
Publikováno v:
Targeted oncology [Target Oncol] 2024 May; Vol. 19 (3), pp. 383-400. Date of Electronic Publication: 2024 Apr 21.
Autor:
Li Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, China., Cao S; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.; Department of Nursing, Fudan University Shanghai Cancer Center, Shanghai, China., Lv F; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China., Chen GL; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, China.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Oct 30; Vol. 15, pp. 1461090. Date of Electronic Publication: 2024 Oct 30 (Print Publication: 2024).
Autor:
Leveille E; Center of Molecular and Cellular Oncology, Yale University, New Haven, Connecticut., Kothari S; Center of Molecular and Cellular Oncology, Yale University, New Haven, Connecticut., Cosgun KN; Center of Molecular and Cellular Oncology, Yale University, New Haven, Connecticut., Mlynarczyk C; Center of Molecular and Cellular Oncology, Yale University, New Haven, Connecticut., Müschen M; Center of Molecular and Cellular Oncology, Yale University, New Haven, Connecticut.; Department of Immunobiology, Yale University, New Haven, Connecticut.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Sep 04; Vol. 14 (9), pp. 1577-1580.
Autor:
Ramesh S; Structural Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Go M; Structural Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Call ME; Structural Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Call MJ; Structural Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 23; Vol. 15, pp. 1426795. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).
Autor:
DO J; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, U.S.A., Yenwongfai LN; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, U.S.A., DO SI; Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; sungim.do@samsung.com., Kim SW; Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Na K; Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea naky0430@khu.ac.kr.
Publikováno v:
Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 2953-2960.